WeirFoulds represents Antibe Therapeutics in $28.75M bought deal public offering
On June 30, 2020, Antibe Therapeutics Inc. (“Antibe”) (TSXV: ATE) announced that it closed its previously announced bought deal public offering of units (the “Units”) raising aggregate gross proceeds…